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Abstract
Background/Aims: This study tested the hypothesis that individuals with chronic obstructive 
pulmonary disease (COPD) have more small vessel disease and more severe disease than 
an age- and gender- matched hospital patient comparison group. Methods: This was a 
single centre, case-control study of 151 individuals with COPD (FEV1/VC) < 0.7 recruited 
consecutively immediately after respiratory function tests at a Melbourne teaching hospital 
over a 4 month period in 2010. Controls were individuals with normal respiratory function 
tests recruited contemporaneously from the same centre. Retinal images were obtained with 
a nonmydriatic camera (KOWA or Canon CR5-45NM), deidentiifed and graded by two trained 
graders for microvascular retinopathy (Wong and Mitchell classification), and vessel calibre 
using a computer-assisted method and Knudtson’s modification of the Parr-Hubbard formula. 
Differences in microvascular retinopathy and vessel calibre between COPD patients and the 
comparison group were examined using Fisher’s exact test or the t test (StataCorp, Texas). 
Results: Patients with COPD had more microvascular retinopathy (121, 80% and 76, 50%; 
OR 3.98, 95%CI 2.39 to 6.64) and more severe disease (42, 28% and 18, 12%; OR 2.85, 95% 
CI 1.55 to 5.23) than other hospital patients. COPD remained an independent determinant 
of microvascular retinopathy (OR 4.56, 95%CI 2.49 to 8.36) after adjusting for gender, 
hypertension, smoking, and diabetes duration. Retinal arterioles and venules were wider in 
patients with COPD than other hospital patients (mean difference +6.5µm, 95% confidence 
interval 1.4 to 11.6; and +17.4µm, 95%CI 9.4 to 25.5, respectively). Larger venules were more 
common in younger individuals (+0.6 µm, 0.1 to 1.17) with more cigarette exposure (+0.3 
µm, 0.2 to 0.5) or a lower serum albumin (+23.0 µm, 6.0 to 40.0). Venular calibre was not 
different in current and former smokers (p=0.77). There were trends for venules to be larger 
with more severe COPD (lower FEV1/VC, p=0.09) and with CT-demonstrated emphysema 
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IntroductionChronic obstructive pulmonary disease (COPD) affects 10% of adults over the age of 
40, and is a leading cause of  ill-health and death [1]. It is characterised by airflow limitation 
due to inflammation and remodelling, but is more complex than airways disease alone. 
Thus, extrapulmonary complications are common, including vascular disease, diabetes, malnutrition, osteoporosis, depression, and macular degeneration [2-5].
Patients with COPD are more likely to be diagnosed with cardiovascular disease (OR 
2.46 95% CI 2·02–3·00; p<0·0001), with a two to five times greater risk of ischaemic heart 
disease, cardiac arrhythmias, heart failure, or arterial disease [6]. In addition patients with 
COPD are more likely to have hypertension (OR 1·33, 95% CI 1·13–1·56; p = 0·0007).
Most patients with COPD have been smokers and smoking contributes to many of 
these complications. Smoking affects the vasculature, blood pressure, and renal function, 
through diverse mechanisms such as oxidative stress, endothelial dysfunction, hypoxaemia 
and autonomic dysregulation [7-9]. However, smoking-independent mechanisms may also 
be important, and the release of inflammatory mediators from the lungs into the systemic 
circulation is increasingly recognised in the initiation and exacerbation of comorbid disease [2]. Most previous studies of cardiac disease in COPD have focused on coronary artery 
stenosis, and ignored small vessel disease. No previous study has examined small vessel 
disease in COPD, apart from one that found an association between larger venular calibre and a reduction in FEV1, FEV1/VC and lung density (p all < 0.05) [10].
Hypertensive/microvascular retinopathy is associated with an increased risk of cardiac 
events [11, 12]. Characteristic features include diffuse and focal arteriolar narrowing, 
arteriovenous nicking, haemorrhage and exudates. Arteriolar narrowing and venular 
dilatation are both also associated with increased cardiac risk. However the determinants 
of small vessel calibre are complex. For example, arteriole calibre is reduced in males and 
with increasing age, hypertension, atherosclerosis and renal failure [13]. Venular calibre is 
increased in diabetes, smoking, inflammation, obesity, dyslipidemia and hypoxemia [11, 14-
17]. The present study determined the frequency and severity of hypertensive/microvascular 
retinopathy features including calibre, in a single centre cohort of individuals with COPD. 
Retinal small vessel examination represents a surrogate for direct examination of the systemic microvasculature.
Materials and Methods
Study design
This was a single centre, case-control study of Caucasian individuals with COPD recruited consecutively from a Melbourne metropolitan teaching hospital (Northern Health) over a 4 month period in 2010. The 
comparison group were age- and gender-matched hospital patients with normal respiratory function 
tests recruited during the same period. The researchers were undergraduate medical students who were seconded to a research project.
Recruitment, data capture and retinal photographs were coordinated in a single episode. Participants 
with COPD or with normal respiratory function tests were recruited immediately after testing. They were then assisted by the researcher to complete a basic structured demographic and medical questionnaire 
and to undergo retinal photography. Participants were not assessed for behavioural information apart from 
(p=0.06). Conclusions: Hypertensive/microvascular disease is more common and more severe 
in patients with COPD. This is likely to contribute to the associated increase in cardiac risk.
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smoking history, and cigarette pack years. Retinal images were examined for microvascular retinopathy and 
vessel calibre at the Centre for Eye Research Australia. The frequency and severity of retinal abnormalities 
were then compared between COPD patients and the comparison group, and the likely determinants 
examined in a multivariate analysis. There were no changes to the study design after its commencement and no interim analyses. 
The study was approved by the Northern Health Human Research Ethics Committee according to the 
Principles of the Declaration of Helsinki, and all participants provided signed, informed consent.
Participants
Participants with COPD or with normal respiratory function tests were recruited immediately after 
testing.Respiratory tests were performed using a computerized spirometer (Sensor Medics Legacy 29D, 
Yorba Linda, USA) by a trained technician according to a standard protocol [18, 19].
COPD was diagnosed when participants had a ratio of forced expiratory volume in one second (FEV1) 
to forced vital capacity (FVC) < 70% and no increase after bronchodilator treatment [20]. Individuals were 
recruited regardless of whether they were newly-diagnosed or treated, and whether they had diagnosed 
hypertension or not. There was no randomisation of participants. 
The controls were age- and gender-matched hospital clinic patients with normal respiratory function 
tests, and no previous diagnosis of COPD, asthma or bronchiectasis. They were approached as they waited 
for respiratory function testing or for medical clinic review.
Hypothesis
Our hypothesis was that small vessel disease was more abundant and more severe in subjects with COPD than in an age- and gender-matched comparison group.
Outcomes
The primary outcome was to demonstrate an association of COPD with microvascular retinopathy or 
changed retinal vessel calibre. The secondary outcome was to demonstrate that any effect was independent 
of other vascular risk factors.
Eligibility criteria
Inclusion criteria were age over 18 years, FEV1/VC <70% without an increase after bronchodilator 
therapy, and the provision of written informed consent. Exclusion criteria were where the vessel calibre in 
the retinal images was ungradeable.
Measurements
Clinical features: Participants were assisted to complete a structured questionnaire for demographics 
(age, gender, race), and vascular risk factors (smoking, cigarette pack years, diabetes, hypertension, 
dyslipidemia), and laboratory test results (haemoglobin, lipids, estimated glomerular filtration rate [GFR] 
based on the MDRD formula) were obtained from their electronic medical records. Generally, the diagnoses 
of hypertension, diabetes and dyslipidemia were based on self-reported physician-made diagnoses (resting BP > 140/90 mm Hg; random blood sugar > 11.1mmol/L; the need for statin treatment, respectively). A list 
of current medications was extracted from the medical record, and the number of antihypertensive agents 
counted for each participant by a physician. The extent of cigarette use was recorded as cigarette pack years. 
A low serum albumin was defined as < 36 g/l. Emphysema was demonstrated radiologically on a chest 
computerized tomographic (CT) scan within the previous 12 months.
COPD: COPD severity was graded according to the ‘GOLD’ Guidelines (Global Initiative for Chronic 
Obstructive Lung Disease, www.goldCOPD.org). Briefly, mild COPD severity corresponded to FEV1 > 80% 
normal; moderate to FEV1 50 – 79% normal; severe to 30 – 49% normal; and very severe to FEV1 <30% 
normal. The use of home oxygen therapy but no other COPD-specific treatment was noted.
Retinal imaging and grading for retinopathy: All participants underwent colour retinal photography 
of both eyes using a non-mydriatic retinal camera (KOWA 7, Optimed, or Canon CR5-45NM, Canon, Japan). 
Standard 45° images were taken of both eyes, with at least one centred on the macula and another on the 
optic disc. All retinal images were deidentified, examined for incidental abnormalities and haemorrhage 
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with red-free manipulation, and graded for microvascular retinopathy (Wong and Mitchell classification) 
[21], independently by two trained graders, an ophthalmologist and a medical student. In all cases, the grade 
of the more severely-affected eye was used. Any disparities in grading were discussed, and a consensus reached.
Microvascular retinopathy was classified as mild (arteriovenous nicking, focal arteriolar narrowing, 
silver-wiring or a decreased arteriovenous ratio), moderate (haemorrhage or exudates) or severe (papilloedema). 
Retinal calibre measurements: Retinal vessel calibre was measured by a trained grader at the Centre 
for Eye Research Australia (Victoria, Australia) who was masked to subject identity and used a standardized 
protocol [22, 23]. All vessels passing through a zone 0.5-1 disc diameters from the optic disc margin were 
examined using a semi-automated computer imaging program (University of Wisconsin, WI), and measures 
based on the 6 largest vessels were combined into the Central Retinal Artery and Vein Equivalents  (CRAE 
and CRVE). This method was highly reproducible with intra-class correlation coefficients of 0.99 (95% CI 
0.98 -0.99) for the CRAE and 0.94 (95% CI 0.92- 0.96) for the CRVE.
Sample size
This represented a pilot study since there were no previous data that enabled us to determine an appropriate participant number.
Statistical methods
Differences in clinical characteristics and vessel calibre between patients with COPD and the 
comparison group were compared using Fisher’s exact test or the t test. 
Possible determinants of retinopathy or calibre were examined using univariate linear regression. 
Likely determinants of retinopathy and calibre were then examined in multivariate regression models. 
Statistical analyses were performed using GraphPad or STATA version 11.2 software (Stata Corp, College 
Station, TX, USA). Statistical significance was set at p < 0.05 and trends at <0.10.
Results
Clinical features
One hundred and fifty-four patients with COPD and 156 of the comparison group were 
recruited. The recruitment rate was > 95% of the individuals approached in each group. 
Three patients with COPD and 5 controls were excluded because their retinal images were 
ungradeable. These were the only exclusions. This meant that the results from 151 cases and 
151 of the comparison group were studied.
Patients with COPD had an average age of 69 + 9.7 years (range 42 – 78 years) and 80 (53%) 
were male (Table 1). Their mean FEV1:VC was 50% (range 21-69), and their mean FEV1 was 
53% (range 17-107). Most (143, 95%) had been smokers with an average cigarette exposure of 46.2 + 27.3 pack years. Eight had never smoked but had long-term exposure to smoke and/or occupational dusts.
Overall, patients with COPD were more likely to have been smokers, to have smoked 
more, to require more anti-hypertensive medications, and to have worse renal function than 
other hospital patients (Table 1). However, COPD patients were not different from hospital 
controls in their likelihood of having hypertension, diabetes, or dyslipidaemia, nor, if they had diabetes, in its duration (Table 1).
Microvascular retinopathy
Microvascular retinopathy was more common in patients with COPD than other hospital 
patients.  One hundred and twenty-one (80%) COPD patients but only 76 (50%) controls 
had a microvascular retinopathy (OR 3.98, 95%CI. 2.39 to 6.64, p < 0.001) (Table 2) (Fig. 1).
In the COPD patients, the microvascular retinopathy was mild in 79 (52%) and moderate in 
42 (28%). Both the mild and moderate retinopathy were more common in patients with COPD 
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Table 2. Retinal abnormalities in patients with COPD and hospital controls. NA – not applicable
Fig. 1. Features of mi-crovascular retinopathy 
in patients with COPD: (a) dot and blot haemor-
rhages (arrows); (b) ar-
teriovenous nicking (ar-
row); (c) decreased ar-
teriole (large arrow) and 
venous (small arrow) ratio; d. focal arteriolar 
narrow (big arrow); (e) 
arteriovenous nicking 
(arrow) with cotton 
wool spot to the left; and f. tortuous arterioles and venules.
Table 1. Clinical features in patients with COPD and hospital controls. BMI - body mass index, eGFR - esti-
mated glomerular filtration rate
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than hospital controls (OR 1.76, 95%CI 1.11 to 2.78, p = 0.03, and OR 2.85, 95%CI 1.55 to 5.23, 
p = 0.001 respectively). None of the patients in either group had a severe microvascular 
retinopathy with papilloedema.
Thirty-eight (25%) patients with COPD had a retinal haemorrhage compared with 18 
(12%) hospital controls (OR 2.46, 95%CI 1.34 to 4.59, p = 0.005) (Fig. 1). Most retinal bleeds 
were small and unlikely to have any visual impact.
On univariate analysis, the major determinants of microvascular retinopathy were 
male gender (p = 0.01), smoking history (p = 0.02), hypertension (p < 0.01), number of 
antihypertensive medications (p < 0.01), diabetes duration (p = 0.04), and diagnosis of COPD 
(p < 0.01) (Table 2). COPD diagnosis remained a significant risk factor for microvascular 
retinopathy (OR 4.56, 95%CI 2.49 to 8.36, p < 0.01) after adjusting for gender, hypertension, 
and diabetes duration, smoking history and pack years (Table 3). Where COPD, smoking and 
pack years were all considered, only COPD was an independent determinant.
Retinal vessel calibre
Eighty-six patients in this study who had had a chest CT scan and their 86 matched 
controls were examined for retinal arteriole and venular calibre. They comprised 38 males 
(44%) and 48 females (56%), with a mean age of 65.9 ± 7.5 years (range 42 – 78). Their median FEV1/FVC was 49% (range 22 to 69%), and median FEV1 1.04 litres (range 0.38 to 
3.30). Four (5%) had GOLD grade 1, 36 (42%) had grade 2, 35 (40%) grade 3, and 11 (13%) 
grade 4 disease. Fifteen (17%) patients required home oxygen support.  Sixty-five (76%) 
with COPD had a chest CT scan, which indicated emphysema in 39 (60%).
Forty-seven (55%) patients were current and 39 (45%) were former smokers, and their 
mean cigarette exposure was 44.2 ± 27.5 pack years. The former smokers had stopped 6 years previously (median, range one month to 35 years).
Controls comprised 36 (42%) males and 50 (58%) females with a mean age of 66.1 ± 
9.9 years (range 46 to 85). Fourteen (16%) were current smokers.
Patients with COPD had more cigarette exposure (p<0.001) and worse renal function 
(p < 0.001) than the comparison group, but were not different in terms of prevalence of hypertension, diabetes or dyslipidaemia or of BMI. 
Arteriolar calibre. Patients with COPD had larger arterioles than other hospital patients 
(mean CRAE 153.8 ± 17.1 µm and 147.3 ± 17.1 µm, respectively; mean difference 6.5µm, 
95%CI 1.4 to 11.6, p = 0.01).
Arteriole calibre was not different in current and former smokers (154.3 + 18.0 µm and 153.1 + 16.2 µm, respectively; mean difference -1.2 µm, 95%CI 6.2 to -8.6, p = 0.75). Fourteen 
Table 3. Determinants of microvascular retinopathy
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patients   had a  low serum albumin < 36 g/L. Arterioles from patients with a low serum albumin 
demonstrated a trend to increased calibre compared with those with a normal serum albumin 
(158.4 ± 10.95 µm and 149.7 ± 15.8 µm, p = 0.07). Arterioles were wider in COPD patients with a 
lower blood pressure (mean difference -9.0µm, 95%CI -16.3 to -1.8, p<0.01), lower BMI (mean 
difference - 0.7 µm, 95%CI -1.2 to - 0.1, p<0.01), and increased pack years (0.9 µm, 0.6 to1.8, 
p = 0.04), and there was a trend with eGFR (0.2, 95%CI -0.3 to 0.4, p = 0.09) (Table 4).
Retinal arteriole calibre was then compared in patients with COPD and controls using 
multivariate linear analysis in different models after adjusting for determinants identified in the univariate analysis (Table 5). The difference in calibre persisted after adjusting for blood 
pressure, BMI and eGFR (p < 0.01), and for blood pressure, BMI, eGFR and pack years (p = 
0.03) but not for blood pressure, BMI and pack years (p = 0.06). 
Venular calibre. Patients with COPD had larger venules than controls (mean CRVE 
229.4 ± 28.0 µm and  211.9 ± 25.5 µm respectively; mean difference 17.4 µm, 95%CI 9.4 to 25.5, p < 0.001).
Venular calibre was not different in current and former smokers (230.2 ± 29.8 µm and 
228.4 ± 26.1 µm, respectively; mean difference -1.8µm, 95%CI -13.9 to 10.4, p = 0.77).
Venules were larger in patients with COPD and a low serum albumin (240.9 ± 27.5 µm) 
than in those with normal levels (217.9 ± 17.6 µm, p = 0.01). Venules were also larger in 
COPD patients who were younger (p = 0.02), had diabetes (p = 0.03) and increased pack years (p < 0.01) (Table 4).
Retinal venular calibre was then compared in patients with COPD and controls using multivariate linear regression analysis in different models after adjusting for determinants 
identified in the univariate analysis (Table 5). The difference in calibre persisted after 
adjusting for age and diabetes (p < 0.01), but not with age, diabetes and pack years (p = 0.46).
Retinal vessel calibre and COPD severity. Retinal arteriolar calibre was not associated 
with more severe airways disease as demonstrated by FEV1 (p = 0.13) or FEV1/FVC ratio (p 
Table 4. Univariate analysis of factors associated wtih retinal vascular calibre in patients with COPD. 95%CI: 
95% confidence interval, BMI: body mass index, eGFR: estimated glomerular filtration rate, Low serum Albumin 
- < 36 g/L
Table 5. Differences in retinal vascular calibre between patients with COPD and controls. 95%CI: 95% con-
fidence interval
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= 0.83) nor with emphysema on chest CT scan. Arteriolar calibre was also not different in 
patients with or without emphysema (155.8 ± 16.3µm and 152.1 ± 17.8 µm respectively, p 
= 0.33).
There were trends for larger retinal venules in patients with more severe airways 
disease demonstrated by a lower FEV1, (mean difference in CRVE per 10ml change FEV1 
-11.3µm, 95%CI -24.6 to 2.1, p = 0.10) or lower FEV1/FVC ratio (mean difference in CRVE per 1% change FEV1/FVC ratio – 0.4 µm, 95%CI, -0.8 to 0.1 p = 0.09). There was also a trend 
for larger retinal venules in patients with emphysema compared with those without (235.6 
± 25.0 µm and 224.2 ± 29.5 µm, respectively, mean difference +11.4 µm, 95%CI - 0.4 to 23.4, 
p = 0.06).
Discussion
This study demonstrated that microvascular retinopathy was more common and more 
severe in patients with COPD than in other age- and gender- matched hospital patients. COPD remained an independent determinant of microvascular retinopathy (p<0.01) after 
adjusting for hypertension, smoking, gender and diabetes. In addition, retinal arterioles 
and venules were wider in patients with COPD. Calibre was greater with increased cigarette 
exposure, but did not depend on current smoking status. Venular calibre was also increased 
in patients with a low serum albumin, and there were trends for an association with more severe COPD and CT-demonstrated emphysema.
The study compared retinal abnormalities in patients with COPD and those with normal 
respiratory function. Clinic patients with normal respiratory function tests were used as 
controls because they were well-characterised medically.
Patients with COPD had hypertension, dyslipidemia and diabetes, as often as other 
hospital patients, and diabetes was of similar duration. Patients with COPD required 
more antihypertensive agents and had worse renal function, which may be explained by 
their increased vascular disease.  Blood pressure severity was assessed by the number of 
antihypertensive medications needed for treatment. Blood pressure control is difficult to 
assess, with clinic BP measurements overestimating levels, and ambulatory BP measurements underestimating control.
Diabetes duration rather than diabetic control was used as a risk factor because 
complications are more likely with longer disease duration and control varies over time. 
COPD patients were more likely to have been smokers, and to have smoked more than other 
patients. However some of the COPD patients had never smoked, while half those with 
normal respiratory function had smoked, generally for shorter periods of time.
Both mild and moderate microvascular retinopathy were increased in patients with 
COPD, and COPD was the strongest determinant of microvascular retinopathy even after 
adjusting for hypertension diagnosis, smoking history, gender and diabetes duration.  COPD 
and hypertension share risk factors, the most important of which are probably age and 
smoking. These were examined in the univariate analysis and also taken into account in the multivariate analysis, but the results demonstrated that the effects of COPD persisted. The 
observation that COPD was a risk factor for small vessel disease independent of smoking and 
hypertension suggested hypertension measurement was important or there was a role for 
another COPD-related mechanism, such as inflammation [24]. The finding of microvascular retinopathy itself has implications for COPD patients since population-based studies have 
demonstrated it predicts cardiac events [25, 26], chronic heart failure [27] and stroke, in 
high-risk individuals [28].
Both retinal arteriole and venular calibre were increased in patients with COPD. 
Microvascular dilatation has been found previously in smokers [13] but was demonstrated 
here in former smokers too. Smoking has complex and sometimes long-lasting effects on the 
small vessels. It contributes to arteriolar narrowing through atherosclerosis, hypertension 
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and renovascular disease, and to venular dilatation by toxin-induced endothelial damage, 
reduced vasoactive mediators, tissue hypoxaemia and autonomic dysregulation.
There were trends for an association between wider venules and more severe COPD, 
consistent with a shared determinant, such as smoking, or  a causal relationship, for example, 
hypoxaemia or chronic low grade infection. This study also suggested a trend between venular dilatation and emphysema. Previously, pulmonary microvascular dilatation in 
emphysema was thought to reflect the destruction of local supporting tissue and subsequent 
remodelling [29], but it is likely that early vascular widening occurs, at least in part, because 
of inflammation and not primarily from pulmonary damage.
Larger venules were associated with low serum albumin levels in COPD too. The 
albumin levels possibly reflected inflammation from smoking-induced damage, low grade 
respiratory tract infections or COPD exacerbations. A low serum albumin correlates better 
with inflammation than the elevated white cell counts that also occur with stress and 
corticosteroid use, but which are absent in the frail unwell. C reactive protein levels may 
be normal or low in inflammation where there is impaired hepatic synthetic function. Low 
serum albumin was unlikely to reflect malnutrition since the patients’ average BMI was 
above the recommended normal range and few had severe end-stage COPD.
The major strengths of this study were that participants were well-characterised, the 
recruitment rate was high, COPD was diagnosed with spirometry, and widely- accepted, 
reproducible grading systems were used to assess microvascular retinopathy and calibre. 
Hospital patients were used as the comparison group because their comorbidities were 
well-documented and, although they were more likely to be smokers and any difference in 
vessel calibre therefore less pronounced, the cohort was still large enough to demonstrate a 
difference with COPD patients. The major limitations of this study were that it was performed at a single centre, and that the causes of microvascular retinopathy and calibre changes 
are complex. In the first instance these results need to be confirmed in an independent 
study. However these results still indicate that patients with COPD have an increased risk 
of microvascular disease compared with other hospital patients and hence that hospital resources might focus on this disease group.
Conclusion
Patients with COPD have a greater risk of microvascular disease and more severe 
disease than other hospital patients [30]. Retinal vessels are larger in patients with COPD. 
Cigarette exposure and chronic inflammation may contribute to microvascular disease, and 
the systemic microvasculature, including the coronary small vessels, will be affected too. In other, population-based studies, retinal venular dilatation predicts cardiac events [12].
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